1Suppliers
15Customers
3Debt Items
3Related Chains

Source-Backed Evidence Depth

China SXT Pharmaceuticals, Inc. (SXTC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships
2Distinct source URLs
7High confidence
0.724Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

China SXT Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
LGCL Lucas GC Limited 72% Reciprocal relationship from LGCL graph: formance obligation to the corporate customers, we should bear the loss of the corporate customers for breach of contract on our own, and then independently c…

China SXT Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
SUXUANTANG SUXUANTANG 92% Suxuantang had one significant customer which accounted for 68.72% of our total revenue during the year ended March 31, 2025.
DRUG-STORES DRUG-STORES 90% We currently manufacture 200 Regular TCMP products listed on China Pharmacopoeia (version 2020) Parts I and IV for hospitals and drug stores in treatment of various diseases or serving as dietary sup…
HOSPITALS HOSPITALS 90% We currently manufacture 200 Regular TCMP products listed on China Pharmacopoeia (version 2020) Parts I and IV for hospitals and drug stores in treatment of various diseases or serving as dietary sup…
CHINESE-INVESTMENT-CONTROLLED-ENTERPRISES-INCORP CHINESE-INVESTMENT-CONTROLLED-ENTERPRISES-INCORP 62% llion users or collect data that affects or may affect national security must be subject to network data security review by the relevant Cyberspace Administration of the PRC. The deadline for public …
HUANGSHAN-PANJIE-INVESTMENT-MANAGEMENT-CO-LTD HUANGSHAN-PANJIE-INVESTMENT-MANAGEMENT-CO-LTD 62% used in operating activities of $1,928,053 for the year ended March 31, 2024, representing an increase in cash outflow of $417,280. The increase in cash outflow in operating activities primarily resu…
JIANGSU-HEALTH-PHARMACEUTICAL-INVESTMENT-MANAGEM JIANGSU-HEALTH-PHARMACEUTICAL-INVESTMENT-MANAGEM 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
JIANGSU-SUTAITANG-E-COMMERCE-CO-LTD JIANGSU-SUTAITANG-E-COMMERCE-CO-LTD 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
JIANGSU-SUXUANTANG-PHARMACEUTICAL-CO-LTD JIANGSU-SUXUANTANG-PHARMACEUTICAL-CO-LTD 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
JIANGXI-BO-SHI-DA-PHARMACEUTICAL-CO-LTD JIANGXI-BO-SHI-DA-PHARMACEUTICAL-CO-LTD 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
JIUZHOUTONG-PHARMACEUTICAL-CO-LTD JIUZHOUTONG-PHARMACEUTICAL-CO-LTD 62% ugh the growing pipeline of new TCMP products. Our diverse portfolio of products and our new product pipelines include products for high-incidence and high-mortality conditions in the PRC, such as ca…
REFORM-MEDICAL-MARKETING-CO-LIMITED REFORM-MEDICAL-MARKETING-CO-LIMITED 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
STREETERVILLE-CAPITAL-LLC STREETERVILLE-CAPITAL-LLC 62% NOTE 10 – BORROWINGS (CONTINUED) Long-term borrowings (Continued) Long-term bank loans are loans the Company borrowed from Jiangsu Taizhou Rural Commercial Bank which are valid from November 2, 2022 …
TAIZHOU-JIEDA-CONCRETE-CO-LTD TAIZHOU-JIEDA-CONCRETE-CO-LTD 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
TAIZHOU-JIUTIAN-PHARMACEUTICAL-CO-LTD TAIZHOU-JIUTIAN-PHARMACEUTICAL-CO-LTD 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…
TAIZHOU-RENJI-CHINESE-TRADITIONAL-MEDICINE-PIECE TAIZHOU-RENJI-CHINESE-TRADITIONAL-MEDICINE-PIECE 62% He was the CEO of Taizhou Suxuantang, the VIE Entity from May 2017 to February, 2018. From January 2015 to May 2017, he was the vice manager of Taizhou Suxuantang. As vice manager of Taizhou Suxuanta…

China SXT Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SXTC-DEBT Debt stack $648,865 90% Market cache reports total debt of $648,865.
SXTC-DEBT-12847 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-03-31.
SXTC-DEBT-12846 Warrants outstanding: 0.01 90% xbrl warrant detail from xbrl 2023-09-30.

China SXT Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for China SXT Pharmaceuticals, Inc..

China SXT Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
SXTC-OWNER-CITADEL-ADVISORS-LLC CITADEL ADVISORS LLC 90% 13F overlay lists CITADEL ADVISORS LLC as top holder; 8 tracked holders.

China SXT Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BON Bon Natural Life Limited 100.00 2
WDC Western Digital Corporation 100.00 2
LGCL Lucas GC Limited 36.29 1 ['supplier']
🔐
SXTC
Unlock SXTC Supply Chain Data
Verified relationships include:
LGCLLucas GC LimitedSupplier72%
SUXUANTANGSUXUANTANGCustomer92%
DRUG-STORESDRUG-STORESCustomer90%
+16 more relationships locked
Subscribe — View plans →